JAGUAR HEALTH, INC. Extinguishment of Debt, Amount
JAGUAR HEALTH, INC. (JAGX) reported Extinguishment of Debt, Amount of $11.23 million for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-11.
Discontinued › Notes › Debt
us-gaap:ExtinguishmentOfDebtAmount · last filed 2022-03-11
- JAGUAR HEALTH, INC. extinguishment of debt, amount for the quarter ending 2020-12-31 was -$150.00K.
- JAGUAR HEALTH, INC. extinguishment of debt, amount for fiscal 2020 was $11.23M.
| Period end | Extinguishment of Debt, Amount 3 month | Extinguishment of Debt, Amount 9 month | Extinguishment of Debt, Amount 12 month |
|---|---|---|---|
| 2020-12-31 | -$150.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $11.23M 10-K · filed 2022-03-11 | |
| 2020-09-30 | $11.38M 10-Q · filed 2021-11-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |